CAS: 236406-61-4; Tert-Butyl 2,7-Diazaspiro[4.5]Decane-7-Carboxylate

该化合物是一种化学化合物,其特点是独特的环环结构,包括含有氮原子的双环框架,该化合物具有一个异环功能组,有助于其溶解性和再活动.二氮细胞的存在表明,其结构内含有两个氮原子,可影响其化学行为,包括与生物系统的潜在相互作用.该化合物的环环球性质往往具有有趣的相近特性,使其成为药用化学和药物设计中感兴趣的一个对象.此外,碳箱酸酯组可以参与各种化学反应,例如酯化和恐吓,增强合成应用中的多用途.

结构式图片

相似化合物

1279856-08-4 885268-42-8 1086395-71-2

欧盟法规

C&L通报

合成工艺路线路线简述

    2,7-Diazaspiro[4.5]Decane-1,3,6,8-Tetraone置于lithium Aluminium Tetrahydride,三氟乙酸体系中,用 四氢呋喃,乙醇,二氯甲烷 用作溶剂,化学反应 48.0H,反应生成2,7-二氮杂螺[4.5]癸烷-2-羧酸叔丁酯,2,7-二氮杂螺[4.5]癸烷-7-羧酸叔丁酯
    参考文献:吡咯烷和哌啶基螺二胺支架的合成和差异官能化
    标题:吡咯烷和哌啶基螺二胺支架的合成和差异官能化
    摘要:描述了一系列螺二胺支架的合成和差异取代/保护.还描述了基于2,7-二氮杂螺[4.5]癸烷选择性获得两种单-N-甲基异构体的方法.与该化学反应有关的关键前体易于重排,并报道了解决该问题的方法.而直接单声道-氨基甲酰化作用(boc)无效,选择性地脱保护对称对称的二胺衍生的双重boc保护的衍生物可提供mono-Boc变体.还进行了n-芳基化,以引入2-氯-5-吡啶基部分的一系列单取代的螺二胺为例,该2-氯-5-吡啶基部分是优先的烟碱激动剂亚结构,以提供单芳基化的仲和叔螺二胺变体.
    Doi:10.1016/j.Tet.2013.03.064

    海关参考信息

    专利信息


    专利号:US-10280189-B2
    优先权日:2012-07-17
    标题:Method for the synthesis of aminoalkylenephosphonic acid
    发明人:BURCK SEBASTIAN; LECLERCQ CEDRIC NICOLAS; NOTTE PATRICK
    权利人:MONSANTO TECHNOLOGY LLC
    摘要:A method for the synthesis of an aminoalkylenephosphonic acid or its phosphonate esters including the following steps: a) forming, in the presence of an aldehyde or ketone and an acid catalyst, a reaction mixture by mixing a compound having at least one HNR 1 R 2 moiety or a salt thereof, with a compound having one or more P—O—P anhydride moieties, the moieties having one P atom at the oxidation state (+III) and one P atom at the oxidation state (+III) or (+V), wherein the ratio of moles of aldehyde or ketone to N—H moieties is 1 or more and wherein the ratio of N—H moieties to P—O—P anhydride moieties is 0.3 or more, and b) recovering the resulting aminoalkylenephosphonic acid having compound or its phosphonate esters.

    专利号:US-9676799-B2
    优先权日:2012-07-17
    标 题 :Method for the synthesis of N-(phosphonomethyl)glycine
    发明人:BURCK SEBASTIAN; BRUYNEEL FREDERIC; NOTTE PATRICK
    权利人:STRAITMARK HOLDING AG
    摘要:A method for the synthesis of N-(phosphonomethyl)glycine or one of its derivatives selected from the group consisting of its salts, its phosphonate esters, or its phosphonate ester salts, which includes the steps of: a) forming, in the presence an acid catalyst, a reaction mixture having 2,5-diketopiperazine, formaldehyde and a compound including one or more P-0-P anhydride moieties, the moieties having one P atom at the oxidation state (+III) and the other P atom at the oxidation state (+III) or (+V), to form N,N′-bisphosphonomethyl-2,5-diketopiperazine, its mono- to tetra phosphonate esters, the dehydrated forms of N,N′-bisphosphonomethyl-2,5-diketopiperazine and the phosphonate esters of its dehydrated forms; and b) hydrolyzing the N,N′-bisphosphonomethyl-2,5-diketopiperazine, its dehydrated forms or their phosphonate esters to obtain N-(phosphonomethyl)glycine or one of its derivatives selected from the group consisting of its salts, its phosphonate esters and its phosphonate ester salts.

    专利号:US-10464958-B2
    优先权日:2012-07-17
    标题 :Method for the synthesis of alpha-aminoalkylenephosphonic acid
    发明人:NOTTE PATRICK; COGELS SAMUEL; BURCK SEBASTIAN
    权利人:MONSANTO TECHNOLOGY LLC
    摘要:The present invention is related to a new method for the synthesis of alpha-aminoalkylenephosphonic acid or its phosphonate esters comprising the steps of forming a reaction mixture by mixing a P—O—P anhydride moiety comprising compound, having one P-atom at the oxidation state (+III) and the other P-atom at the oxidation state (+III) or (+V), an aminoalkanecarboxylic acid and an acid catalyst, wherein said reaction mixture comprises an equivalent ratio of alpha-aminoalkylene carboxylic acid to P—O—P anhydride moieties of at least 0.2, and recovering the resulting alpha-aminoalkylene phosphonic acid compound or an ester thereof from the reaction mixture.

    专利号:US-9150599-B2
    优先权日:2012-07-17
    标 题 :Method for the synthesis of N-(phosphonomethyl)glycine
    发明人:BURCK SEBASTIAN; NOTTE PATRICK
    权利人:STRAITMARK HOLDING AG
    摘要:A method for the synthesis of N-(phosphonomethyl) glycine or one of its derivatives selected from the group of its salts, its phosphonate esters and its phosphonate ester salts, including the steps of: a) forming a reaction mixture having an acid catalyst, N,N′-bis(carboxymethyl)-2,5-diketopiperazine and a compound having one or more P—O—P anhydride moieties, wherein the moieties have one P atom at the oxidation state (+III) and the other P atom at the oxidation state (+III) or (+V), to form N,N′-bis(phosphonomethyl)-2,5-diketopiperazine, its dehydrated forms or their phosphonate esters; b) hydrolyzing the reaction mixture to form N-(phosphonomethyl)glycine or one of its derivatives selected from the group consisting of its salts, its phosphonate esters and its phosphonate ester salts.

    专利号:US-2014342177-A1
    优先权日:2011-12-07
    标 题 :Synthesis of cupronickel nanowires and their application in transparent conducting films
    发明人:WILEY BENJAMIN
    权利人:UNIV DUKE
    摘要:A method of synthesis to produce a conductive film including cupronickel nanowires. Cupronickel nanowires can be synthesized from solution, homogeneously dispersed and printed to make conductive films (preferably < 1,000 Ω/sq) that preferably transmit greater than 60% of visible light.

    专利号:US-10183962-B2
    优先权日:2014-02-25
    标 题:Synthetic oligomers of Neisseria meningitis serogroup X and process of preparing them
    发明人:GILL DAVINDER; HARALE KISHORE; CHHIKARA MANOJ KUMAR
    权利人:MSD WELLCOME TRUST HILLEMAN LABORATORIES PVT LTD
    摘要:The present invention relates to synthesis of novel higher oligomers and process of preparing the same. In particular the present invention relates to the chemical synthesis of oligomers of Neisseria meningitidis serogroup X (‘hereinafter Men-X), more particularly tetramer. The present invention provides Men-X capsular oligomers obtained from synthetic pathway using purified saccharides of specific chain length and provides said novel oligomers as candidates for the development of conjugate vaccine against bacterial meningitis caused due to Men-X infections.
    四川恒康科技发展有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hengkangtech.com
    企业联系电话:1398-0413900👤
    📞四川恒康科技发展有限公司 ⚠️参考联系方式
    联系人:余盛良
    电话:1398-0413900
    手机:13330964498
    传真:86-028-60651388
    邮箱:slyu@hengkangtech.com,dpu@hengkangtech.com
    通信地址: 成都市蒲江县松华乡(寿卧路旁)
    邮编: 610000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:成都市蒲江县松华乡(寿卧路旁)
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知